more_reports

Esperion Therapeutics Inc.

ESPR:NASDAQ

Esperion is the Lipid Management Company committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.

streetwise book logo Streetwise Company Fact Sheet

2024/7/17 19:05:01

(ESPR:NASDAQ)

Streetwise Reports Articles

08/29/2022 - View Article